Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The FDA-approved maximum weekly dose for weight management (Wegovy) is 2.4 mg
Tirzepatide, which is sold under the brand name Mounjaro for diabetes and Zepbound for weight loss, is similar to semaglutide, but is a GLP-1/GIP agonist
Theyve inadvertently doubled their dose
Why Does Injection Site Matter for Semaglutide
It activates the GIP receptor with approximately equal potency to native GIP, but activates the GLP-1 receptor with roughly five times lower potency than native GLP-1
Pharmacokinetics and effects on cyst(e)ine in plasma and urine Saitoh T., et al
US$ 21.46
US$ 23.04
US$ 25.66
US$ 28.86
US$ 23.03
US$ 22.95
US$ 27.78
US$ 27.51
